Rechercher des projets européens

14 projets européens trouvés

Recherche sur 125080 projets européens

 TERMINÉ 

SPIDIA for Personalized Medicine - Standardisation of generic Pre-analytical procedures for In-vitro DIAgnostics for Personalized Medicine (SPIDIA4P)

Date du début: 1 janv. 2017, Date de fin: 31 déc. 2020,

Molecular in vitro diagnostics and biomedical research have allowed great progress in personalised medicine but further progress is limited by insufficient guidelines for pre-analytical workflow steps (sample collection, preservation, storage, transport, processing etc.) as well as by insufficient quality assurance of diagnostic practice. This allows using compromised patients’ samples with post c ...
Voir le projet

 21

 TERMINÉ 

Cancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in blood (CANCER-ID)

Date du début: 1 janv. 2015, Date de fin: 31 déc. 2019,

Blood-based biomarkers such as Circulating Tumor Cells (CTCs), circulating free tumor DNA (cfDNA) and microRNAs (miRNAs) have the potential to improve the development of personalized medicines for cancer patients. This is of particular importance when biopsies of the primary tumor or metastases are not accessible (e.g. at early disease stages or in minimal residual disease) or possible and the ass ...
Voir le projet

 34

 TERMINÉ 

European Clinical Research Infrastructures Network - Integrating Activity (ECRIN-IA)

Date du début: 1 janv. 2012, Date de fin: 31 déc. 2017,

ECRIN is a distributed ESFRI-roadmap pan-European infrastructure designed to support multinational clinical research, making Europe a single area for clinical studies, taking advantage of its population size to access patients. Servicing multinational trials started during its preparatory phase, and it now applies for an ERIC status by 2011. The ERIC budget will be restricted to core activities re ...
Voir le projet

 48

 TERMINÉ 

Framework to respond to regulatory needs of future nanomaterials and markets (FutureNanoNeeds)

Date du début: 1 janv. 2014, Date de fin: 31 déc. 2017,

Rapidly developing markets such as green construction, energy harvesting and storage, advanced materials for aerospace, electronics, medical implants and environmental remediation are potential key application targets for nanomaterials. There, nanotechnology has the potential to make qualitative improvements or indeed even to enable the technology. Impacts range from increased efficiency of energy ...
Voir le projet

 26

 TERMINÉ 

Santé Publique et Santé Mentale : Nouveaux besoins, nouvelles formations : quelle employabilité des usagers en Europe ?

Date du début: 1 sept. 2014, Date de fin: 31 août 2017,

...ed. They must have access to employment like any other citizens. The project is built on the expertise of network competent partners from five different countries: Romania, Switzerland, France, Luxembourg and Belgium. It consists of psychosocial structures specialized in employment, of training centers in mental health issues and of research centers and universities, specialized in those matters. ...
Voir le projet

 5

 TERMINÉ 

Tutorat Européen en Psychiatrie et Santé Mentale pour les jeunes professionnels

Date du début: 1 sept. 2014, Date de fin: 31 août 2017,

...a European tour through three centers of excellence to new workers from 2015. During these three years of experimentation, an evaluation of the device through the center of health research located in Luxembourg, which has a great expertise on the subject, will be lead. Throughout these three years, the device will be adjusted and corrections will be implemented. This project contributes to the rec ...
Voir le projet

 6

 TERMINÉ 

Integrated DEsign and AnaLysis of small population group trials (IDEAL)

Date du début: 1 nov. 2013, Date de fin: 30 avr. 2017,

There exist more than 7000 rare diseases worldwide and the European Society of Paediatric Oncology stated that 75% of rare diseases affect children and 30% of rare disease patients die before the age of five. Usual statistical methods for proving efficacy and safety of therapies fail to provide cost-efficient and reliable results in small populations. There is a pressing need to integrate a broad ...
Voir le projet

 10

 TERMINÉ 

Development of a universal influenza vaccine based on tandem core technology (FLUTCORE)

Date du début: 1 sept. 2013, Date de fin: 31 mars 2017,

"FLUTCORE will develop a novel universal influenza A virus (IAV) vaccine based on the tandem core vaccine platform. Recent influenza pandemics have emphasized the urgent need for better vaccines that are reactive with multiple IAV subtypes and that are no longer dependent on intimate knowledge of the prevalent virus. We propose to replace the existing seasonal IAV vaccine with a virus like particl ...
Voir le projet

 7

 TERMINÉ 

Biomarker Applications for Nanotechnology and Imaging in Diabetes (UroSense)

Date du début: 1 janv. 2012, Date de fin: 31 déc. 2015,

...programme brings leading edge academic European LifeScience capacities of Diabetes research at Dublin City University, Ireland, together with the high-profile protein research center of University of Luxembourg to establish innovative biomarker utilisation. The nano-biotechnologies developed with established life science applications of Tethis S.p.A of Milano, Italy will be the SME partner to tran ...
Voir le projet

 6

 TERMINÉ 

PROTEOMIC IDENTIFICATION OF BIOMARKERS IN BIOFLUIDS AND IN PRECLINICAL MODELS FOR THE EARLY DIAGNOSIS AND PROGNOSIS OF CANCER (PROT*BIO*FLUID) (PROTBIOFLUID)

Date du début: 1 août 2011, Date de fin: 31 juil. 2015,

1.6 million people are killed worldwide each year due to ovarian, endometrial, bladder and prostate cancers. The key to making treatment breakthrough is early diagnosis.PROTBIOFLUID is a new network for developing innovative early diagnostic techniques and for spreading this knowledge through the medical community by a systematic exchange of staff to create high impact benefits to patients and tra ...
Voir le projet

 2

 TERMINÉ 

Traditional Chinese Medicine in the Post-genomic era: identifying lead therapeutic compounds against cancer (TCMCANCER)

Date du début: 1 mars 2009, Date de fin: 28 févr. 2013,

"This application aims at identifying and characterizing a set of lead therapeutic compounds against cancer (breast, lung and brain), based on current knowledge from Traditional Chinese Medicine (TCM). TCM has a very long tradition in the prevention and treatment of a variety of diseases yet, in contrast to target-oriented Western medicine, TCM uses a holistic and synergistic approach, which can b ...
Voir le projet

 1

 TERMINÉ 

European coordination action on human biomonitoring (COPHES)

Date du début: 1 déc. 2009, Date de fin: 30 nov. 2012,

This proposal has been elaborated by a consortium of 35 partners coming from 27 European countries and including scientists, government institutions and authorities, NGOs and industry. The main goal is to develop a coherent approach to HBM in Europe as requested by ACTION 3 of the EU Environment and Health Action Plan through coordination of ongoing and planned HBM activities. The project will exp ...
Voir le projet

 40

 TERMINÉ 

Sustaining access to Tissues and data frOm Radiobiological Experiments (STORE)

Date du début: 1 avr. 2009, Date de fin: 30 sept. 2012,

The sharing of data and biomaterials from publicly funded experimental radiation science adds enormous value to the original investment. Sharing will yield substantial scientific rewards through re-analysis and new investigations. The goal of STORE is to generate a platform that will allow the storage and retrieval of both data and the corresponding biological material from past, current and futur ...
Voir le projet

 9

 TERMINÉ 

Novel MS-based strategies to Discover and Evaluate Cancer Biomarkers in urine: Application to Diagnosis of Bladder Cancer (DECanBio)

Date du début: 1 mars 2008, Date de fin: 31 juil. 2012,

In clinical studies, proteomics and transcriptomics allow the comparison of samples from different patients and hold special promise for the discovery of novel biomarkers and the development of “personalized medicine” approaches. Yet, translating recent discoveries into daily medical practice takes time and despite intensified researchers’ interest and investments, the rate of introduction of nove ...
Voir le projet

 9